Needham & Company Reiterates a 'Buy' on Benchmark (BHE); Posts Healthy 4Q, Considering Thailand Flooding Impact

Needham & Company reiterates a 'Buy' on Benchmark (NYSE: BHE) price target raised from $18.50 to $21.00.

Analyst, Sean K.F. Hannan, says, "Overall, we believe BHE may finally be poised to demonstrate consistent and sustainable growth through: (1) a solid string of new business wins; (2) quickly mitigated issues from Thailand flooding; (3) a supportive outsourcing environment; (4) a refocused sales group; and (5) a macro backdrop that at least appears somewhat stable (albeit not very robust)."

"Our 1Q becomes $570M in revs. and $0.20 EPS (incl. opt.), vs. prior $560M & $0.13. For 2012, estimates are $2.40B and $1.12, vs. our previous $2.40B and $1.02."

For an analyst ratings summary and ratings history on Benchmark click here. For more ratings news on Benchmark click here.

Shares of Benchmark closed at $17.99 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Needham Starts Faeth Therapeutics (FTH) at Buy
• Deere (DE) PT Lowered to $728 at UBS as Agricultural Machinery Cycle Gets Closer
• Beike (BEKE) PT Raised to $23 at Morgan Stanley